     |
 |
$4.85 billion allotted to pay settlements against Vioxx® New Ortho Evra® Study Links the Patch to Blood Clots Two Federal Vioxx® Trials Delayed Secretly-Developed FDA Rule Puts Americans at Risk Jury Selection Begins in 4th Vioxx® Trial Guidant Corp. Recalls 50,000 Defibrillators Goldberg & Osborne Donates Funds to Mohave Downwinders Pfizer Suspends Sales of Bextra® Celebrex® Joins Vioxx® in Cardiovascular Side Effects Anti-Depressants Linked to Suicidal Behavior Vioxx® Withdrawn from the Market Crestor Exhibiting Side Effects Similar to Withdrawn Baycol Zyprexa and Other Anti-psychotic Drugs Linked to Diabetes FDA Finalizes Ephedra Ban |
|
|